• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生长激素(GH)替代疗法对日本生长激素缺乏症儿童动脉粥样硬化风险的有利影响。

Favorable Impacts of Growth Hormone (GH) Replacement Therapy on Atherogenic Risks in Japanese Children with GH Deficiency.

作者信息

Kohno Hitoshi, Tanaka Toshiaki, Fujieda Kenji, Chihara Kazuo, Seino Yoshiki, Irie Minoru, Takano Kazue

机构信息

Department of Endocrinology and Metabolism, Fukuoka Children's Hospital, Fukuoka, Japan.

出版信息

Clin Pediatr Endocrinol. 2012 Apr;21(2):15-20. doi: 10.1297/cpe.21.15. Epub 2012 Mar 24.

DOI:10.1297/cpe.21.15
PMID:23926406
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3698902/
Abstract

Growth hormone (GH) affects body composition and atherogenic risk factors. Severe hyperlipidemia may develop in GH-deficient adults as a consequence of continuous GH deficiency. We investigated changes in lipid profiles in 158 Japanese children (103 boys and 55 girls) with GH deficiency who had been enrolled in the Pfizer International Growth Database Japan during 3 yr of GH replacement therapy to evaluate whether GH treatment has beneficial effects on atherogenic risk factors. Total cholesterol (TC), high-density lipoprotein cholesterol (HDLC), low-density lipoprotein cholesterol (LDLC) and atherogenic index were evaluated before treatment and then once a year during treatment. The mean baseline TC was within the normal range in both boys and girls. Seventeen (16.5%) of the 103 boys and 18 (32.7%) of the 55 girls, however, had a TC level over 200 mg/dl before treatment. The mean TC level showed a significant decrease in girls. In a separate analysis, patients of both sexes with a TC level > 200 mg/dl showed significantly decreased TC. LDLC decreased significantly only in girls, while HDLC showed no change in either sex. The atherogenic index decreased significantly in girls. GH replacement therapy in children with GH deficiency had beneficial effects on lipid metabolism and atherogenic risk in both sexes. Early GH treatment would produce lipid metabolism benefits in these patients.

摘要

生长激素(GH)会影响身体成分和动脉粥样硬化风险因素。由于持续的生长激素缺乏,生长激素缺乏的成年人可能会出现严重的高脂血症。我们调查了158名日本生长激素缺乏儿童(103名男孩和55名女孩)在接受3年生长激素替代治疗期间血脂谱的变化,这些儿童已被纳入辉瑞国际生长数据库日本分库,以评估生长激素治疗对动脉粥样硬化风险因素是否有有益影响。在治疗前以及治疗期间每年评估一次总胆固醇(TC)、高密度脂蛋白胆固醇(HDLC)、低密度脂蛋白胆固醇(LDLC)和动脉粥样硬化指数。男孩和女孩的平均基线总胆固醇均在正常范围内。然而,103名男孩中有17名(16.5%)和55名女孩中有18名(32.7%)在治疗前总胆固醇水平超过200mg/dl。女孩的平均总胆固醇水平显著下降。在一项单独分析中,总胆固醇水平>200mg/dl的男女患者总胆固醇均显著下降。仅女孩的低密度脂蛋白胆固醇显著下降,而高密度脂蛋白胆固醇在男女中均无变化。女孩的动脉粥样硬化指数显著下降。生长激素缺乏儿童的生长激素替代治疗对男女的脂质代谢和动脉粥样硬化风险均有有益影响。早期生长激素治疗将给这些患者带来脂质代谢方面的益处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/803c/3698902/b4c6090515ad/cpe-21-015-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/803c/3698902/b4c6090515ad/cpe-21-015-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/803c/3698902/b4c6090515ad/cpe-21-015-g001.jpg

相似文献

1
Favorable Impacts of Growth Hormone (GH) Replacement Therapy on Atherogenic Risks in Japanese Children with GH Deficiency.生长激素(GH)替代疗法对日本生长激素缺乏症儿童动脉粥样硬化风险的有利影响。
Clin Pediatr Endocrinol. 2012 Apr;21(2):15-20. doi: 10.1297/cpe.21.15. Epub 2012 Mar 24.
2
Long-term prospective study of body composition and lipid profiles during and after growth hormone (GH) treatment in children with GH deficiency: gender-specific metabolic effects.生长激素缺乏症患儿生长激素(GH)治疗期间及治疗后身体成分和血脂谱的长期前瞻性研究:性别特异性代谢效应
J Clin Endocrinol Metab. 1998 Nov;83(11):3890-6. doi: 10.1210/jcem.83.11.5261.
3
Low-dose GH replacement improves the adverse lipid profile associated with the adult GH deficiency syndrome.低剂量生长激素替代疗法可改善与成人生长激素缺乏综合征相关的不良血脂状况。
Clin Endocrinol (Oxf). 2002 Apr;56(4):525-32. doi: 10.1046/j.1365-2265.2002.01508.x.
4
Unfavourable impact of growth hormone (GH) discontinuation on body composition and cholesterol profiles after the completion of height growth in GH-deficient young adults.生长激素(GH)缺乏的年轻成年人身高增长完成后,停用生长激素对身体成分和胆固醇水平的不利影响。
Diabetes Obes Metab. 1999 Sep;1(5):293-6. doi: 10.1046/j.1463-1326.1999.00048.x.
5
Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement.生长激素(GH)缺乏儿童在接受12个月GH替代治疗前后的血清同型半胱氨酸浓度。
Clin Endocrinol (Oxf). 2004 Nov;61(5):607-11. doi: 10.1111/j.1365-2265.2004.02142.x.
6
Favorable impact of growth hormone treatment on cholesterol levels in turner syndrome.
Clin Pediatr Endocrinol. 2012 Apr;21(2):29-34. doi: 10.1297/cpe.21.29. Epub 2012 Mar 24.
7
Effect of discontinuation of long-term growth hormone treatment on carbohydrate metabolism and risk factors for cardiovascular disease in girls with Turner syndrome.特纳综合征女孩长期生长激素治疗中断对碳水化合物代谢及心血管疾病危险因素的影响。
J Clin Endocrinol Metab. 2002 Dec;87(12):5442-8. doi: 10.1210/jc.2002-020789.
8
Left ventricular mass and function in children with GH deficiency before and during 12 months GH replacement therapy.生长激素缺乏症患儿在12个月生长激素替代治疗前及治疗期间的左心室质量和功能
Clin Endocrinol (Oxf). 2004 May;60(5):630-6. doi: 10.1111/j.1365-2265.2004.02026.x.
9
Beneficial effect of growth hormone on atherogenic risk in children with growth hormone deficiency.生长激素对生长激素缺乏症儿童动脉粥样硬化风险的有益作用。
J Pediatr. 1995 Jun;126(6):953-5. doi: 10.1016/s0022-3476(95)70220-2.
10
Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database.希恩综合征:金赛-辉瑞国际代谢数据库中91例患者的基线特征及2年生长激素替代治疗的效果
Eur J Endocrinol. 2005 Apr;152(4):581-7. doi: 10.1530/eje.1.01881.

引用本文的文献

1
Biological effects of recombinant human growth hormone therapy on metabolism in children with growth hormone deficiency: a review.重组人生长激素治疗对生长激素缺乏症儿童代谢的生物学效应:综述
J Pediatr Endocrinol Metab. 2025 May 6. doi: 10.1515/jpem-2025-0057.
2
Effect of recombinant human growth hormone therapy on blood lipid and carotid intima-media thickness in children with growth hormone deficiency.重组人生长激素治疗对生长激素缺乏症儿童血脂及颈动脉内膜中层厚度的影响。
Pediatr Res. 2018 May;83(5):954-960. doi: 10.1038/pr.2017.271. Epub 2018 Jan 17.

本文引用的文献

1
Lipid screening and cardiovascular health in childhood.儿童期血脂筛查与心血管健康
Pediatrics. 2008 Jul;122(1):198-208. doi: 10.1542/peds.2008-1349.
2
Efficacy and safety of growth hormone (GH) in the treatment of adult Japanese patients with GH deficiency: a randomised, placebo-controlled study.生长激素(GH)治疗成年日本生长激素缺乏症患者的疗效和安全性:一项随机、安慰剂对照研究。
Growth Horm IGF Res. 2006 Apr;16(2):132-42. doi: 10.1016/j.ghir.2006.03.012. Epub 2006 May 15.
3
Complications in adults with growth hormone deficiency--a survey study in Japan.
成人生长激素缺乏症的并发症——日本的一项调查研究
Endocr J. 2004 Oct;51(5):479-85. doi: 10.1507/endocrj.51.479.
4
Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy.接受或未接受生长激素替代治疗的垂体功能减退成年患者的恶性疾病和心血管疾病发病率
J Clin Endocrinol Metab. 2004 Jul;89(7):3306-12. doi: 10.1210/jc.2003-031601.
5
Direct causes of death in Japanese patients with hypopituitarism as analyzed from a nation-wide autopsy database.
Eur J Endocrinol. 2004 Feb;150(2):149-52. doi: 10.1530/eje.0.1500149.
6
Hypercholesterolemia and obesity in adult patients with hypopituitarism: a report of a nation-wide survey in Japan.成年垂体功能减退症患者的高胆固醇血症和肥胖症:日本全国性调查的报告
Endocr J. 2003 Dec;50(6):759-65. doi: 10.1507/endocrj.50.759.
7
Growth hormone induces low-density lipoprotein clearance but not bile acid synthesis in humans.生长激素可促进人体低密度脂蛋白的清除,但不影响胆汁酸的合成。
Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):349-56. doi: 10.1161/01.ATV.0000110657.67317.90. Epub 2003 Dec 4.
8
A study of carotid intima-media thickness in GH-deficient Japanese adults during onset among adults and children.一项关于日本成年和儿童期起病的生长激素缺乏症成年患者颈动脉内膜中层厚度的研究。
Eur J Endocrinol. 2003 Mar;148(3):333-8. doi: 10.1530/eje.0.1480333.
9
New criteria of normal serum lipid levels in Japanese children: the nationwide study.日本儿童正常血脂水平的新标准:全国性研究。
Pediatr Int. 2002 Dec;44(6):596-601. doi: 10.1046/j.1442-200x.2002.01634.x.
10
Premature mortality and hypopituitarism.过早死亡与垂体功能减退
Lancet. 2001 Jun 16;357(9272):1973-4. doi: 10.1016/S0140-6736(00)05036-4.